For Immediate Release
Delafield, Wis., March 12, 2015 – Annie Bartosz, founder of Gold In September® (G9) has been chosen as one of the “100 Everyday Amazing” individuals who are working to inspire others in the fight against cancer.
Massachusetts General Hospital Cancer Center created and supports the one hundred initiative. Every year, the initiative honors 100 Everyday Amazing individuals and groups whose commitment to the fight against cancer inspires others to take action. This year, Bartosz was one of more than 800 to be nominated for the distinction.
Bartosz was nominated by Debra Cordeiro from Rhode Island, who wrote, “Gold in September has grown from Annie’s love of her twin brother into a groundswell of support that has reached far beyond her town of Hartland, Wisconsin. I cannot think of anyone else who embodies ‘Everyday Amazing’ more than Annie Bartosz!”
Bartosz, who lost her twin brother to cancer in 2012, is determined to turn the world gold in September for kids battling cancer, the same way October is pink for breast cancer. While turning the world gold, Bartosz is raising vital funds for childhood cancer research and clinical trials.
On May 26, 2015, Bartosz will be honored as the one hundred celebrates all of the 100 Everyday Amazing honorees at the eighth annual gala in Boston, Massachusetts.
Funds raised by the one hundred initiative support Massachusetts General Hospital Cancer Center, which benefits cancer patients worldwide. Since 2008, the one hundred has raised more than $7 million. Visit www.theonehundred.org to learn more about the initiative and meet all of the honorees.
Gold In September® Charitable Trust (G9) is a registered 501(c)(3) tax-exempt organization with a vision to color the world gold so that every child, everywhere will survive cancer. G9 is dedicated to raising awareness, inspiring action, creating hope, finding cures and defeating childhood cancer. Visit www.goldinseptember.com to learn more about G9.
Mind if we hang out
in your inbox?
We only email once or twice a month, always relevant to how we're working to beat neuroblastoma and other childhood cancers.
Thank you for subscribing!
Something went wrong.